This grant funds Florida-based biomedical research targeting cancer, cardiovascular, stroke, and pulmonary diseases, especially those linked to tobacco, to improve prevention, diagnosis, and treatment.
Funder: Florida Department of Health
Due Dates (Anticipated): December 2026 (Letter of Intent) | January 2027 (Full application)
Funding Amounts: Up to $1.5M for 36–48 months (varies by category; see details below).
Summary: Supports biomedical research in Florida targeting cancer, cardiovascular, stroke, and pulmonary diseases, especially those linked to tobacco use, to advance prevention, diagnosis, treatment, and economic development.
Key Information: Letter of Intent required before application; only Florida-based universities and research institutes are eligible.
The James and Esther King Biomedical Research Program, administered by the Florida Department of Health, funds innovative biomedical research to improve the prevention, diagnosis, treatment, and cure of cancer, cardiovascular disease, stroke, and pulmonary disease in Florida. The program places special emphasis on diseases related to tobacco use and aims to expand biomedical knowledge, foster collaborations, integrate research into healthcare training, attract external funding, and stimulate economic growth in related sectors. Projects must demonstrate clear relevance to the program's disease focus areas and are expected to have a direct impact on the health of Floridians.